文献速递其他结缔组织病

抗Jo1阳性抗合成酶综合征患者中鉴定出识别组氨酰tRNA合成酶新表位的自身反应性T细胞

Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase.
PubMed 文献 · Ann Rheum Dis · 2025-10-25

本研究旨在鉴定抗Jo1阳性抗合成酶综合征(ASyS)患者中组氨酰tRNA合成酶(HisRS)的新T细胞表位,并分析自身反应性T细胞及其TCR库。通过体外结合实验筛选出与HLA-DRB1*03:01高亲和力结合的肽段HisRS41-55,并用四聚体在12例HLA-DRB1*03:01阳性ASyS患者外周血单个核细胞中检测到HisRS+CD4+T细胞(6/12例),TCR测序显示共享的Vα和Vβ基因使用,且2例患者治疗后HisRS+CD4+T细胞持续存在,1例患者初诊和随访间检测到2个相同的T细胞克隆。

要点

  • 鉴定出HisRS新表位HisRS41-55,与HLA-DRB1*03:01高亲和力结合。
  • 12例HLA-DRB1*03:01阳性ASyS患者中6例外周血可检测到HisRS+CD4+T细胞。
  • HisRS+CD4+T细胞TCR库显示共享的Vα和Vβ基因使用,部分克隆在治疗后持续存在。

核心结论

  • 抗Jo1阳性ASyS患者中存在靶向HisRS新表位的自身反应性T细胞,提示对HisRS蛋白多样表位的T细胞反应性。
  • 这些自身反应性HisRS+CD4+T细胞的持续存在及特定克隆可能参与疾病过程。

研究设计与样本

  • 研究设计:选择HisRS N端区域具有适当MHC锚定残基的肽段进行体外结合实验,筛选出与HLA-DRB1*03:01结合亲和力最高的肽段HisRS41-55用于HLA-II类四聚体研究。
  • 样本:HLA-DRB1*03:01阳性ASyS患者外周血单个核细胞(PBMCs),n=12。
  • 方法:体外肽段刺激PBMCs,肽-HLA-DRB1*03:01四聚体检测HisRS+CD4+T细胞,并对捕获的T细胞进行单细胞TCR测序分析TCR库。

主要发现

  • 鉴定出HisRS上对HLA-DRB1*03:01具有高亲和力的新T细胞表位。
  • 在12例患者中有6例(n=6/12)的PBMCs中检测到自身反应性HisRS+CD4+T细胞。
  • HisRS+CD4+T细胞的TCR库分析显示共享的Vα和Vβ基因使用。
  • 2例患者(P2和P4)治疗后HisRS+CD4+T细胞持续存在,1例患者(P2)初诊和随访间检测到2个相同的T细胞克隆。

关键数值与推荐

  • 肽段HisRS41-55与HLA-DRB1*03:01结合亲和力最高,被选用于四聚体研究。
  • HLA-DRB1*03:01阳性ASyS患者(n=12)中6例检测到HisRS+CD4+T细胞。

临床怎么用

  • 原文未涉及临床实践建议。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Anti-Jo1+ antisynthetase syndrome (ASyS) is characterised by autoantibodies targeting histidyl t-RNA synthetase (HisRS), association with HLA-DRB1*03:01 and a distinct clinical phenotype including interstitial lung disease, myositis, arthritis, and mechanic's hands. Previous studies of autoreactive HisRS-specific CD4+T cells point to yet undiscovered T cell epitopes. We aimed to identify new epitopes on HisRS to investigate the presence of autoreactive T cells and their corresponding T-cell receptor (TCR) repertoire from patients with ASyS. METHODS: Peptides from HisRS N-terminal region with appropriate major histocompatibility complex (MHC) anchor residues were selected for in vitro binding assays. The peptide (HisRS41-55) with the highest HLA-DRB1*03:01 binding affinity was selected for studies with HLA-class II tetramers. Peripheral blood mononuclear cells (PBMCs) from patients with ASyS with HLA-DRB1*03:01 (n = 12) were stimulated in vitro with peptide and peptide-HLA-DRB1*03:01 tetramers were used to detect HisRS+CD4+T cells. Single TCR sequencing of captured T cells allowed analyses of the underlying TCR repertoire. RESULTS: We identified a new T cell epitope on HisRS with high affinity for HLA-DRB1*03:01. Autoreactive HisRS+CD4+T cells were detected in PBMCs of patients (n = 6/12). TCR repertoire analysis of HisRS+CD4+T cells revealed shared gene V-alpha and beta usages. Moreover, HisRS+CD4+T cells persisted after treatment in 2 patients (P2 and P4) and 2 identical T cell clones were detected between the initial and follow-up time points in 1 patient (P2). CONCLUSIONS: Autoreactive T-cells targeting a new HisRS epitope were identified indicating T cell reactivity to diverse epitopes of the HisRS protein in patients with anti-Jo1 autoantibodies. Furthermore, we demonstrated the TCR repertoire of autoreactive HisRS+CD4+T cells in patients. Persistence of these T-cells and specific clones may be contributing to disease.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Galindo-Feria AS, Sharma RK, Dubnovitsky A, et al. Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase. Ann Rheum Dis. 2025. PMID: 41139557. doi:10.1016/j.ard.2025.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。